Betty Cohn is a student in the Master of Bioethics program. In May 2019, she completed her BA in Biomedical Ethics from Binghamton University. This degree was part of the Individualized Major Program in which she created the curriculum and completed an IRB approved thesis titled “The Ethics of Genetic Testing.” In addition, in 2017, she completed the summer research program at Tel Aviv University where she worked on a project titled “The Ethics of Individualized Genomic Analysis.” Her research interests include the ethical implications involved in genetic testing, genetic screening and genomic analysis. She recently had the paper, “The Ethics of Big Pharma: A Response to ‘Developing Drugs for Developing Countries’” accepted at the Israel Organizational Behavior Conference at Tel Aviv University.
- Ethical implications involved in genetic testing, genetic screening and genomic analysis
- BA, Biomedical Ethics, Binghamton University